ESOPHAGOGASTRIC CANCER
Clinical trials for ESOPHAGOGASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGOGASTRIC CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGOGASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple-Drug cocktail shows promise for tough stomach cancer
Disease control OngoingThis study tests whether combining three drugs—nivolumab (an immunotherapy that unleashes the immune system), FOLFOX (standard chemotherapy), and regorafenib (a targeted therapy)—can safely control HER2-negative metastatic esophagogastric cancer. The trial enrolled 39 adults with…
Matched conditions: ESOPHAGOGASTRIC CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:56 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called KFA115, alone or with pembrolizumab, in people with advanced cancers like lung, melanoma, and kidney cancer. The main goal is to find a safe dose and understand side effects. About 126 participants will take part to see if the treatm…
Matched conditions: ESOPHAGOGASTRIC CANCER
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New drug shows promise for hard-to-treat stomach cancer
Disease control OngoingThis study tests a drug called amivantamab in 25 people with a specific type of stomach or esophagus cancer that has a change in the EGFR or MET gene. The goal is to see if the drug can shrink tumors and is safe. Participants must have already tried at least one other treatment.
Matched conditions: ESOPHAGOGASTRIC CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New light treatment aims to unblock esophageal cancer Patients' throats
Symptom relief OngoingThis early-phase trial tests a light-activated drug therapy (VTP) to open up blocked food pipes in 12 people with advanced esophageal or stomach cancer who have trouble swallowing. Doctors will find the safest light dose to shrink tumors blocking the throat. The goal is to ease s…
Matched conditions: ESOPHAGOGASTRIC CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 04:55 UTC
-
Your teeth might reveal hidden cancer risk
Knowledge-focused OngoingThis study looks at whether tooth enamel loss (dental erosion) can be a simple, non-invasive clue for detecting esophagogastric and other cancers. Researchers will compare dental erosion in 174 people with various cancers and healthy volunteers. The goal is to understand how comm…
Matched conditions: ESOPHAGOGASTRIC CANCER
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC